Sarrazin, C., Schwendy, S., Möller, B., Dikopoulos, N., Buggisch, P., Encke, J., . . . Berg, T. (2011). Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks. Gastroenterology, 141(5), . https://doi.org/10.1053/j.gastro.2011.07.019
Chicago Style (17th ed.) CitationSarrazin, Christoph, et al. "Improved Responses to Pegylated Interferon Alfa-2b and Ribavirin by Individualizing Treatment for 24-72 Weeks." Gastroenterology 141, no. 5 (2011). https://doi.org/10.1053/j.gastro.2011.07.019.
MLA (9th ed.) CitationSarrazin, Christoph, et al. "Improved Responses to Pegylated Interferon Alfa-2b and Ribavirin by Individualizing Treatment for 24-72 Weeks." Gastroenterology, vol. 141, no. 5, 2011, https://doi.org/10.1053/j.gastro.2011.07.019.